Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 7
2018 4
2019 2
2020 7
2021 8
2022 7
2023 6
2024 8
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia.
Iolascon A, Andolfo I, Russo R, Sanchez M, Busti F, Swinkels D, Aguilar Martinez P, Bou-Fakhredin R, Muckenthaler MU, Unal S, Porto G, Ganz T, Kattamis A, De Franceschi L, Cappellini MD, Munro MG, Taher A; from EHA‐SWG Red Cell and Iron. Iolascon A, et al. Among authors: bou fakhredin r. Hemasphere. 2024 Jul 15;8(7):e108. doi: 10.1002/hem3.108. eCollection 2024 Jul. Hemasphere. 2024. PMID: 39011129 Free PMC article.
Emerging Therapies in β-Thalassemia.
Bou-Fakhredin R, Kuo KHM, Taher AT. Bou-Fakhredin R, et al. Hematol Oncol Clin North Am. 2023 Apr;37(2):449-462. doi: 10.1016/j.hoc.2022.12.010. Hematol Oncol Clin North Am. 2023. PMID: 36907614 Review.
Beta-thalassemia: is cure still a dream?
Hodroj MH, Akiki N, Bou-Fakhredin R, Taher AT. Hodroj MH, et al. Among authors: bou fakhredin r. Minerva Med. 2023 Dec;114(6):850-860. doi: 10.23736/S0026-4806.23.08501-4. Epub 2023 Aug 3. Minerva Med. 2023. PMID: 37534831 Review.
Clinical Complications and Their Management.
Bou-Fakhredin R, Motta I, Cappellini MD, Taher AT. Bou-Fakhredin R, et al. Hematol Oncol Clin North Am. 2023 Apr;37(2):365-378. doi: 10.1016/j.hoc.2022.12.007. Hematol Oncol Clin North Am. 2023. PMID: 36907609 Review.
Recommendations for pregnancy in Fanconi anemia.
Matar CF, Bou-Fakhredin R, Russo R, Andolfo I, Iolascon A, Taher AT. Matar CF, et al. Among authors: bou fakhredin r. Expert Opin Biol Ther. 2021 Nov;21(11):1403-1409. doi: 10.1080/14712598.2021.1913119. Epub 2021 Apr 12. Expert Opin Biol Ther. 2021. PMID: 33798394 Review.
Thalassemia and malignancy: An emerging concern?
Hodroj MH, Bou-Fakhredin R, Nour-Eldine W, Noureldine HA, Noureldine MHA, Taher AT. Hodroj MH, et al. Among authors: bou fakhredin r. Blood Rev. 2019 Sep;37:100585. doi: 10.1016/j.blre.2019.06.002. Epub 2019 Jun 22. Blood Rev. 2019. PMID: 31253373 Review.
Unmet needs in β-thalassemia and the evolving treatment landscape.
Njeim R, Naouss B, Bou-Fakhredin R, Haddad A, Taher A. Njeim R, et al. Among authors: bou fakhredin r. Transfus Clin Biol. 2024 Feb;31(1):48-55. doi: 10.1016/j.tracli.2023.12.003. Epub 2023 Dec 20. Transfus Clin Biol. 2024. PMID: 38128605 Review.
Step out of the shadows: a call for action for rare diseases.
Granata F, Bou-Fakhredin R, Cappellini MD, Motta I. Granata F, et al. Among authors: bou fakhredin r. Lancet Haematol. 2024 Jun;11(6):e403. doi: 10.1016/S2352-3026(24)00110-8. Lancet Haematol. 2024. PMID: 38796191 No abstract available.
46 results